Total Payments
$934.50
2024 Payments
$216.73
Companies
16
Transactions
31
Medicare Patients
1,726
Medicare Billing
$206,559
Payment Breakdown by Category
Food & Beverage$934.50 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $934.50 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $245.31 | 4 | $0 (2023) |
| Gilead Sciences, Inc. | $124.99 | 1 | $0 (2018) |
| ABBVIE INC. | $116.85 | 7 | $0 (2024) |
| Celgene Corporation | $115.47 | 5 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $86.59 | 1 | $0 (2018) |
| Medtronic, Inc. | $63.53 | 3 | $0 (2024) |
| EMD Serono, Inc. | $25.99 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $25.00 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $19.06 | 1 | $0 (2024) |
| Abbott Laboratories | $18.85 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $216.73 | 11 | ABBVIE INC. ($73.21) |
| 2023 | $145.85 | 7 | Celgene Corporation ($74.23) |
| 2022 | $65.72 | 4 | ABBVIE INC. ($25.32) |
| 2021 | $138.98 | 2 | BOSTON SCIENTIFIC CORPORATION ($125.00) |
| 2019 | $104.71 | 2 | Boston Scientific Corporation ($90.07) |
| 2018 | $211.58 | 2 | Gilead Sciences, Inc. ($124.99) |
| 2017 | $50.93 | 3 | Olympus America Inc. ($17.37) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/12/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.69 | General |
| Category: Neuroscience | ||||||
| 08/07/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/06/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $25.99 | General |
| 07/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: IMMUNOLOGY | ||||||
| 05/31/2024 | Medtronic, Inc. | NEXPOWDER (Device) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Therapeutic Endoscopy | ||||||
| 05/20/2024 | CapsoVision, Inc. | CapsoCam Plus (Device) | Food and Beverage | Cash or cash equivalent | $15.25 | General |
| Category: Gastroenterology | ||||||
| 04/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Respiratory | ||||||
| 03/06/2024 | Medtronic, Inc. | NEXPOWDER (Device) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Therapeutic Endoscopy | ||||||
| 02/28/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/26/2024 | Medtronic, Inc. | NEXPOWDER (Device) | Food and Beverage | In-kind items and services | $31.22 | General |
| Category: Therapeutic Endoscopy | ||||||
| 01/24/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/05/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/30/2023 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: LUX-Dx_CRM | ||||||
| 05/13/2023 | CONMED Corporation | CONMED HEMOSTASIS (Device) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: GENERAL SURGERY | ||||||
| 05/11/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $28.16 | General |
| Category: Neuroscience | ||||||
| 04/28/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: IMMUNOLOGY | ||||||
| 04/04/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $24.98 | General |
| Category: Neuroscience | ||||||
| 02/08/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.09 | General |
| Category: Neuroscience | ||||||
| 12/13/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.55 | General |
| Category: Neuroscience | ||||||
| 09/13/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/15/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/10/2022 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Heart Failure | ||||||
| 12/02/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL - THERAPIES (Device) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: General Therapies | ||||||
| 11/17/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Gastroenterology | ||||||
| 06/25/2019 | Boston Scientific Corporation | SPYGLASS (Device) | Food and Beverage | In-kind items and services | $90.07 | General |
| Category: BILIARY DEVICES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 564 | 1,086 | $285,458 | $71,994 |
| 2022 | 10 | 522 | 746 | $256,456 | $61,144 |
| 2021 | 9 | 347 | 443 | $175,693 | $41,891 |
| 2020 | 10 | 293 | 356 | $139,913 | $31,530 |
Total Patients
1,726
Total Services
2,631
Medicare Billing
$206,559
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 152 | $39,222 | $13,856 | 35.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 60 | 60 | $39,540 | $11,100 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 101 | 145 | $25,482 | $8,871 | 34.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 53 | 304 | $55,936 | $7,738 | 13.8% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 25 | 99 | $28,809 | $6,051 | 21.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $16,896 | $5,866 | 34.7% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 25 | 96 | $20,160 | $4,743 | 23.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 54 | 55 | $19,745 | $3,771 | 19.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 34 | 36 | $12,528 | $3,750 | 29.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 27 | 28 | $14,588 | $2,146 | 14.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 33 | $6,072 | $2,109 | 34.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $6,480 | $1,993 | 30.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 140 | 218 | $51,288 | $14,068 | 27.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 119 | $39,747 | $11,045 | 27.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 54 | 54 | $45,774 | $10,305 | 22.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 61 | 61 | $26,535 | $7,661 | 28.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 69 | 69 | $20,004 | $5,247 | 26.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 50 | 53 | $30,417 | $4,058 | 13.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 35 | 37 | $12,876 | $3,956 | 30.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 20 | 103 | $18,952 | $2,671 | 14.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 20 | $3,680 | $1,157 | 31.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 12 | 12 | $7,183 | $975.78 | 13.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 90 | $29,400 | $8,967 | 30.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 71 | 108 | $24,656 | $7,516 | 30.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 45 | 45 | $19,510 | $5,594 | 28.7% |
About Dr. Sameer Siddique, MD
Dr. Sameer Siddique, MD is a Gastroenterology healthcare provider based in Cypress, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2009. The National Provider Identifier (NPI) number assigned to this provider is 1053544130.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sameer Siddique, MD has received a total of $934.50 in payments from pharmaceutical and medical device companies, with $216.73 received in 2024. These payments were reported across 31 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($934.50).
As a Medicare-enrolled provider, Siddique has provided services to 1,726 Medicare beneficiaries, totaling 2,631 services with total Medicare billing of $206,559. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Internal Medicine, Gastroenterology
- Location Cypress, TX
- Active Since 08/24/2009
- Last Updated 09/21/2020
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1053544130
Products in Payments
- GENERAL - THERAPIES (Device) $125.00
- Epclusa (Drug) $124.99
- ZEPOSIA (Drug) $115.47
- SPYGLASS (Device) $90.07
- Erleada (Drug) $86.59
- CREON (Drug) $64.24
- NEXPOWDER (Device) $63.53
- XARELTO (Drug) $25.00
- RINVOQ (Biological) $19.84
- FASENRA (Biological) $19.06
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $18.85
- SKYRIZI (Biological) $18.32
- Olympus Hemostasis Devices (Device) $17.37
- RESOLUTION CLIP (Device) $16.84
- Barrx (Device) $16.72
- CapsoCam Plus (Device) $15.25
- CONMED HEMOSTASIS (Device) $14.90
- Entyvio (Biological) $14.64
- LINZESS (Drug) $14.45
- XIFAXAN (Drug) $13.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Cypress
Babatunde Adeyefa, M.d, M.D
Gastroenterology — Payments: $3,951
Gastroenterology $3,951
Kristeen Ogunsanwo, Md, MD
Gastroenterology — Payments: $3,062
Gastroenterology $3,062
Dr. Eric Gou, M.d, M.D
Gastroenterology — Payments: $1,229
Gastroenterology $1,229
Dr. Muhammad Ali Khan, M.d, M.D
Gastroenterology — Payments: $984.00
Gastroenterology $984.00
Thanh-Truc Le, Md, MD
Gastroenterology — Payments: $154.47
Gastroenterology $154.47